33rd MidWinter Retina Symposium: Retina Update 2015

Wauwatosa, WI US
February 14, 2015

To update eyecare professionals in the state of the art of diagnosis and treatment of retinal diseases.

Recent years have witnessed unprecedented expansion in the number of treatment decisions clinicians face when treating patients with retinal disease.   This is due to progress in both the diagnostic and therapeutic arenas.  For more common retinal vascular diseases such as diabetic retinopathy and retinal vein occlusion, there now 5 pharmacologic treatment options.  High impact clinical trials for therapy of common retinal disease are published on a monthly basis. Simultaneously, new technology for imaging the retina is being developed, and integrated into clinical decision-making. It is difficult for practitioners to assimilate the data from the numerous sources, put them in context, and integrate them into their practices.

Summarize the data, provide objective interpretation of the data, and suggestions for practical application into patient care.

Attendees will be informed of topics and learning objectives in advance of the symposium.  Ample time for questions and answers will be allocated to each topic.  Attendees will be asked to grade the speakers, and the program overall for quality and to what degree the objectives were met.

 

ACCME Accreditation Statement:
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
 
AMA Credit Designation Statement:
The Medical College of Wisconsin designates this Live activity for a maximum of 5.5 AMA PRA Category 1 Credits ™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
Hours of Participation for Allied Health Care Professionals
The Medical College of Wisconsin designates this activity for up to 5.5 hours of participation for continuing education for allied health professionals.  
 
Please note there is a $2.50 processing fee for all electronic registrations. 
 
Fellows, Residents and Students must use the Coupon Code RETINA
 
There is a $25.00 cancellation fee
 
This meeting is being supported by Allergan and Genentech

Target Audience

  • Ophthalmologists
  • Optometrists
  • Residents and Fellows
  • Medical students
  • Graduate students
  • Postdoc fellows
  • Vision scientists

Learning Objectives

  • Update practices to include recent advances in options for treatment of diabetic retinopathy
  • Update practices to include recent advances in treatment of retinal vein occlusions
  • Better understand and manage postoperative events after cataract surgery, including inflammatory syndromes, and dislocated intraocular lenses
  • Understand medicolegal implications of retained  crystalline lens material after cataract surgery
  • Improve recognition and understanding of conditions that mimic age-related macular degeneration
Additional information

Contact

Name: 
Kelli Torosian
Phone Number: 
+1 (414) 955-7875
Email: 
ktorosian@mcw.edu
Course summary
Available credit: 
  • 5.50 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 5.50 Hours of Participation
    Hours of Participation credit.
Course opens: 
10/01/2014
Course expires: 
04/30/2015
Event starts: 
02/14/2015 - 7:00am CST
Event ends: 
02/14/2015 - 2:40pm CST
Cost:
$2.50
Add to calendar: 
Crowne Plaza - Milwaukee West
10499 West Innovation Drive
Wauwatosa, WI 53226
United States

Crowne Plaza - Milwaukee West
10499 West Innovation Drive
Wauwatosa, WI 53226
Phone: 414-475-9500
 

 

Program Director:
David Weinberg, MD
Professor of Ophthalmology

Medical College of Wisconsin Speakers:
Thomas Connor, MD
Associate Professor of Ophthalmology
 

Dennis Han, MD
Jack A. & Elaine Klieger Professor of Ophthalmology
Section Chief, Retina Service
 

Judy Kim, MD
Professor of Ophthalmology
 

Kimberly Stepien, MD
Associate Professor of Ophthalmology


William Wirostko, MD
Associate Professor of Ophthalmology
 
Invited Guest Speakers:
Anita Agarwal, MD
Professor of Ophthalmology
Retina, Vitreous & Uveitis Vanderbilt Eye Institute
Nashville, Tennessee

Michael Ip, MD
Associate Professor
University of Wisconsin, Department of Ophthalmology and Visual Sciences
Madison, Wisconsin

All persons in control of content have NO relevant financial relationships to disclose with the exception of the following person(s):

Name

Company

Role

Thomas B. Conner, Jr., MD

Genentech

Consultant

Judy Kim, MD

Notal Vision

Principal Investigator

Genentech

Speaker

Allergan

Consultant

Michael Ip, MD

Allergan

Consultant

Thrombogenics

Consultant

Regeneron

Consultant

Valeant

Consultant

Available Credit

  • 5.50 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 5.50 Hours of Participation
    Hours of Participation credit.

Price

Cost:
$2.50
Please login or register to take this course.